Concepedia

The complexity of chronic kidney disease–mineral and bone disorder across stages of chronic kidney disease

Fabiana G. Graciolli, Kátia R. Neves, Fellype Carvalho Barreto, Daniela Veit Barreto, Luciene M. dos Reis, María Eugênia Fernandes Canziani, Yves Sabbagh, Aluízio B. Carvalho, Vanda Jorgetti, Rosilene M. Elias,

Kidney International · 2017 · 190 citations · 24 references

DOIFull text

Open access

Concepts

References

24

Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee

A. M. Parfitt, Marc K. Drezner, Francis H. Glorieux et al. · Journal of Bone and Mineral Research · 1987 · 5K citations

, , +12

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)

Alison M. MacLeod · Kidney International · 2009 · 2.2K citations

, , +16

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Kenneth Poole, Rutger L. van Bezooijen, N. Loveridge et al. · The FASEB Journal · 2005 · 962 citations

, , +16

Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease

Renata C. Pereira, Harald Jüppner, Carlos E. Azucena-Serrano et al. · Bone · 2009 · 271 citations · Full text

, , +10

Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges

Lourdes Craver, María Paz Marco, Isabel Martínez et al. · Nephrology Dialysis Transplantation · 2007 · 259 citations · Full text

, , +16